Tim Wilsdon recently presented at an education forum at ISPOR Latin America, talking about the challenges that gene therapy poses for value assessment and considerations for the future.
For more information about the conference, click here.
NCDs & long-term antimicrobial therapy
1 in 4 people globally are already affected by NCDs. By 2030, NCDs will cause 55 million deaths per year under ‘business as usual.’1,2 Effective...